{"retracted":false,"update":{"timestamp":1401580800000,"doi":"10.1016/j.bmcl.2014.04.007","type":"err"},"doi":"10.1016/j.bmcl.2013.07.061","journal":"Bioorganic & Medicinal Chemistry Letters","publisher":"Elsevier BV","title":"Corrigendum to “Novel tetrahydropyran analogs as dipeptidyl peptidase IV inhibitors: Profile of clinical candidate (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5-(1H)-yl)tetrahydro-2H-pyran-3-amine (23)” [Bioorg. Med. Chem. Lett. 23 (2013) 5361–5366]"}
